CompletedPhase 3NCT00002766

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Studying T-cell prolymphocytic leukemia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Memorial Sloan Kettering Cancer Center
Principal Investigator: Nicole Lamanna, MD
Memorial Sloan Kettering Cancer Center
Intervention: dactinomycin(biological)
Enrollment: 170 target
Eligibility: 18-120 years · All sexes
Timeline: 1996 – 2011

Study locations (7)

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
New York Medical College, Valhalla, New York, United States
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00002766 on ClinicalTrials.gov

Other trials for T-cell prolymphocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for T-cell prolymphocytic leukemia →

← Back to all trials